Overview

Baclofen Versus Gabapentin in Preventing Postoperative Pain After Laparoscopic Sleeve Gastrectomy

Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study is to compare the possible efficacy of baclofen and gabapentin on postoperative pain in patient with morbid obesity who will undergo laparoscopic sleeve gastrectomy.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Tanta University
Treatments:
Baclofen
Gabapentin
Criteria
Inclusion Criteria:

- - Age between 18-60 years old.

- Both male and female patients will be included.

- Morbidly obese patients scheduled for sleeve gastrectomy with BMI ≥35 kg/m2 with the
presence of comorbidity such as hypertension, arthritis, and diabetes.

- Morbidly obese patients scheduled for sleeve gastrectomy with BMI ≥ 40 kg/m2 without
comorbidity.

- Patients fit for anesthesia and surgery.

Exclusion Criteria:

- Patients with BMI >55 kg/m2.

- Patients with previous procedures for the treatment of obesity.

- Pregnant females and lactating women.

- Patients with psychological or psychiatric disease

- Administration of antiemetic medication or systemic corticosteroids within 24 hours
before surgery

- Patients who experienced vomiting within 24 hours before surgery.

- Patients with history of alcohol or drug abuse.

- Patients with hypersensitivity or contraindications to any of the drugs used in this
study.